Aperio Diagnostics is a spin-out company from Medipex, the NHS commercialisation company for Yorkshire and North Humberside, which is developing a medical device to detect pre-cancerous cells in the cervix. The patented device, which is currently at prototype stage, is targeting the worldwide colcoscopy market and was developed in conjunction with University of Sheffield academics.